The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world first-line serplulimab-based immunochemotherapy for extensive-stage small cell lung cancer: The multicenter ASTRUM-005R study.
 
Lin Wu
Speakers' Bureau - AstraZeneca; Bristol-Myers Squibb; Hengrui Medicine; Innovate Biopharmaceuticals; Lilly; MSD; Pfizer; Roche China
 
ChengPing Hu
No Relationships to Disclose
 
Wenzhong Su
No Relationships to Disclose
 
Yan Yu
No Relationships to Disclose
 
Wei Hong
No Relationships to Disclose
 
Zhigang Liu
No Relationships to Disclose
 
Haichuan Su
No Relationships to Disclose
 
Zhentian Liu
No Relationships to Disclose
 
Caixia Wang
No Relationships to Disclose
 
Qing Pu
No Relationships to Disclose
 
Hui Guo
No Relationships to Disclose
 
Xuhong Min
No Relationships to Disclose
 
Yifei Chen
No Relationships to Disclose